MsDGCN: multi-scale diffusion graph convolutional network for the prediction of drug-disease association
- 7 April 2026
- journal article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1)
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (62472250)
This publication has 45 references indexed in Scilit:
- Leveraging 3D Molecular Spatial Visual Information and Multi‐Perspective Representations for Drug DiscoveryAdvanced Science, 2025
- A Novel Drug–Disease Association Prediction Method Based on Deep Non-Negative Matrix Factorization with Local Graph FeatureInterdisciplinary Sciences: Computational Life Sciences, 2025
- Regulation-aware graph learning for drug repositioning over heterogeneous biological networkInformation Sciences, 2024
- AMDGT: Attention aware multi-modal fusion using a dual graph transformer for drug–disease associations predictionKnowledge-Based Systems, 2023
- A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer’s Disease involving data synthesisNeural Networks, 2023
- Variational gated autoencoder-based feature extraction model for inferring disease-miRNA associations based on multiview featuresNeural Networks, 2023
- REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association predictionComputers in Biology and Medicine, 2022
- Hierarchical graph representation learning for the prediction of drug-target binding affinityInformation Sciences, 2022
- Clinical trial design: Past, present, and future in the context of big data and precision medicineCancer, 2020
- Progression of Chronic Renal FailureArchives of internal medicine (1960), 2003